1996
DOI: 10.1080/01652176.1996.9694651
|View full text |Cite
|
Sign up to set email alerts
|

Field trials with Vedaprofen, a new non‐steroidal anti‐inflammatory drug

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2008
2008
2025
2025

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…It is available as a palatable gel formulation, which has a rapid and almost complete absorption after oral administration in dogs. The oral route has a terminal half-live of the same order of magnitude of the intravenous administration [ 16 ], but with the advantage that the oral route is less stressful to the animal and can be easily administered by the owner during postoperative home care [ 17 ]. Vedaprofen is known to preferentially inhibit the cyclo-oxygenase-2 in dogs [ 18 ], and it is apparently safe in this species, as there was a low incidence of gastrointestinal changes, like vomiting and diarrhea after a long-term treatment for 30–56 days [ 13 , 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…It is available as a palatable gel formulation, which has a rapid and almost complete absorption after oral administration in dogs. The oral route has a terminal half-live of the same order of magnitude of the intravenous administration [ 16 ], but with the advantage that the oral route is less stressful to the animal and can be easily administered by the owner during postoperative home care [ 17 ]. Vedaprofen is known to preferentially inhibit the cyclo-oxygenase-2 in dogs [ 18 ], and it is apparently safe in this species, as there was a low incidence of gastrointestinal changes, like vomiting and diarrhea after a long-term treatment for 30–56 days [ 13 , 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…Studies investigating vedaprofen in dogs and horses found that it is a safe and satisfactory NSAID to prevent the acute release of inflammatory mediators, while providing excellent gastrointestinal and renal tolerance in these especies (BERGMAN et al, 1996;LEES et al, 1998). Although the pharmacokinetics of vedaprofen has been studied in dogs (HOEIJMAKERS et al, 1994), little information is available on its postoperative analgesic effects.…”
Section: Introductionmentioning
confidence: 99%